Navigation Links
JAZZ PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2013 FINANCIAL RESULTS
Date:5/7/2013

70,528(13,988)

(b)

56,54044,356(8,500)

(j)

35,856Research and development

10,747(5,064)

(c)

5,6833,959(515)

(k)

3,444Intangible asset amortization

19,555(19,555)-10,732(10,732)-Interest expense (income), net

7,399(1,229)

(d)

6,170(13)(42)

(l)

(55)Foreign currency gain

271-271---Income from continuing operations before
income tax provision61,05942,132

(e)

103,19135,75221,458

(e)

57,210Income tax provision

17,6341,132

(f)

18,7665,517-5,517
Effective tax rate (g)

28.9%18.2%15.4%9.6%Income from continuing operations

43,42541,000

(h)

84,42530,23521,45851,693Income from continuing operations
per diluted share$
.71$
.37$
.52$
.89(a) Acquisition accounting inventory fair value step-up of $1,545, share-based compensation expense of $709 and

restructuring expense of $42.(b) Share-based compensation expense of $7,005, change in fair value of contingent consideration of $4,500, transaction and integration costs of $1,022, restructuring expense of $907 and depreciation expense of $554.(c) Upfront license fees of $4,000, share-based compensation expense of $1,043 and depreciation of $21.(d) Non-cash interest expense associated with debt discount and debt issuance costs.(e)Sum of the above adjustments.(f)Adjustments to convert the income tax provision to the estimated amount of taxes payable in cash.(g)Income tax provision divided by income from continuing operations before income tax provision.(h)Net of adjustments (e) and (f).(i) Acquisition accounti
'/>"/>

SOURCE Jazz Pharmaceuticals plc
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Isis Pharmaceuticals Announces Proposed Public Offering of Common Stock
2. Alexza Pharmaceuticals to Present at Antiepileptic Drug and Device Trials (AED) XII Conference Highlighting Advances in the Treatment of Epilepsy
3. Kinex Pharmaceuticals and Zenith Technology Corporation announce the execution of a collaborative licensing agreement
4. Isis Pharmaceuticals Announces the Initiation of a Clinical Study of ISIS-STAT3 Rx in Patients with Liver Cancer
5. AcelRx Pharmaceuticals to Hold First Quarter 2013 Financial Results Conference Call and Webcast on May 8, 2013
6. Valeant Pharmaceuticals Provides Efinconazole Update
7. Arena Pharmaceuticals Provides Corporate Update and Reports First Quarter 2013 Financial Results
8. Cumberland Pharmaceuticals Reports First Quarter Financial Results
9. OncoGenex Pharmaceuticals, Inc. Provides Clinical Development Program Overview and Reports Financial Results for First Quarter 2013
10. Webcast Alert: Isis Pharmaceuticals First Quarter 2013 Financial Results Conference Call
11. Optimer Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter 2013 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... MELVILLE, N.Y. , Sept. 16, 2014 /PRNewswire/ ... ), the world,s largest provider of health care ... and medical practitioners, announced today that Stanley M. ... Officer, will participate in a healthcare services panel ... 2014.  Joining Mr. Bergman will be Dr. Stohler, ...
(Date:9/15/2014)... NEW YORK , Sept. 16, 2014 ... the Hereditary Neuropathy Foundation (HNF) announced today an agreement ... Charcot-Marie-Tooth (CMT) disease and support the development of a ... Pharnext will provide financial support to several HNF,s initiatives ... a specific section in the HNF website featuring  HNF ...
(Date:9/15/2014)...  Alere Inc. (NYSE: ALR ) (the ... toxicology, cardiology and diabetes products and services, today confirmed ... CEO Ron Zwanziger , filed a Schedule 13D ... a letter to Gregg J. Powers , Chairman ... in an effort to secure financing to make a ...
Breaking Medicine Technology:Henry Schein To Present At The Leerink Partners Services Roundtable 2Pharnext and the Hereditary Neuropathy Foundation Collaborate to Increase Awareness of Charcot-Marie-Tooth Disease 2Pharnext and the Hereditary Neuropathy Foundation Collaborate to Increase Awareness of Charcot-Marie-Tooth Disease 3Pharnext and the Hereditary Neuropathy Foundation Collaborate to Increase Awareness of Charcot-Marie-Tooth Disease 4Alere Responds To Letter From Former Executives 2
... resistance ... in small cell lung cancer -, SOUTH SAN FRANCISCO, Calif., ... company focused,on oncology, today announced that preliminary data from a Phase ... tumors will be,presented at the 2008 American Association for Cancer Research ...
... BRUSSELS and NEWARK, New Jersey, March 19 ... the UMDNJ-University Hospital,(UH) in Newark, New Jersey from ... interventions to improve outpatient care and,access for people ... teaching hospital provides care for a low-income, minority,population ...
Cached Medicine Technology:Poniard Pharmaceuticals Announces Clinical Data From Picoplatin Oral Phase 1 to Be Presented at the American Association of Cancer Research Annual Meeting 2Poniard Pharmaceuticals Announces Clinical Data From Picoplatin Oral Phase 1 to Be Presented at the American Association of Cancer Research Annual Meeting 3UMDNJ-University Hospital in Newark to Tailor Diabetes Interventions for Low-Income and Minority Groups With Grant From the International Diabetes Federation 2UMDNJ-University Hospital in Newark to Tailor Diabetes Interventions for Low-Income and Minority Groups With Grant From the International Diabetes Federation 3UMDNJ-University Hospital in Newark to Tailor Diabetes Interventions for Low-Income and Minority Groups With Grant From the International Diabetes Federation 4
(Date:9/16/2014)... Va. (PRWEB) September 16, 2014 ... through predictive analytics and targeted clinical programs, today ... announced changes support the Company’s drive to improve ... and targeted clinical programs. On September 2, 2014, ... company, Millennium Health, announced that RxAnte founder and ...
(Date:9/16/2014)... TUESDAY, Sept. 16, 2014 (HealthDay News) -- Illegal drug use ... according to a new federal report. Encouragingly, the ... the use of tobacco products among young people between the ... 2013. The annual survey of 70,000 people aged 12 ... and 2013, substance dependence or abuse problems among this age ...
(Date:9/16/2014)... NEW YORK, NY (September 16, 2014) The ... received the 2014 Higher Education Excellence in Diversity ... oldest and largest diversity-focused publication in higher education. ... national honor recognizing U.S. colleges and universities that ... will be featured along with 82 other recipients ...
(Date:9/16/2014)... 2014A prospective study that compared patient-reported outcomes of ... metastases demonstrates that single fraction radiation therapy (SFRT) ... therapy (MFRT) when pain, function and quality of ... at the American Society for Radiation Oncology,s (ASTRO,s) ... improvements in patients, pain, function and degree of ...
(Date:9/16/2014)... Fresh shiitake mushrooms are a ... They are second-most consumed mushroom worldwide, for their ... and health properties. , In addition to their ... and strengthen the immune system and fight flu ... beta glucans . These medicinal properties have ...
Breaking Medicine News(10 mins):Health News:Millennium Health’s RxAnte Subsidiary Announces Leadership Promotions 2Health News:Millennium Health’s RxAnte Subsidiary Announces Leadership Promotions 3Health News:Fewer U.S. Teens Using Illegal Drugs and Alcohol, Report Finds 2Health News:Columbia University College of Dental Medicine receives diversity award 2Health News:Columbia University College of Dental Medicine receives diversity award 3Health News:Columbia University College of Dental Medicine receives diversity award 4Health News:Single fraction RT as effective as multiple fraction RT for bone metastases 2Health News:Single fraction RT as effective as multiple fraction RT for bone metastases 3Health News:Single fraction RT as effective as multiple fraction RT for bone metastases 4Health News:As Fall Schedules Settle In, Block Stress-Related Illness with Your Own Shiitake Mushroom Log Kit from Lost Creek Mushroom Farm 2Health News:As Fall Schedules Settle In, Block Stress-Related Illness with Your Own Shiitake Mushroom Log Kit from Lost Creek Mushroom Farm 3
... of their work linking mutations in BRAC2 gene leading to ... Journal of Medical Ethics. //Mutations in BRAC2 gene which was ... women has now found to increase the risk of development ... the study also confirmed the relation between BRAC2 mutations and ...
... population its possible to drive safely if they take ... latest edition of Harvard Men's Health Watch, chronic illnesses ... for auto accidents. Even normal, healthy aging can take ... sensory abilities. But simple preparations and precautions can help ...
... risk of picking up infections like MRSA if they glucose ... recent issue of the journal Thorax.// ,The authors base ... in intensive care who required mechanical help with their breathing ... medical and surgical specialties., ,Levels of glucose were measured ...
... from Johns Hopkins had found that patients, who are treated ... follow all the advice of their physicians for effective treatment ... of more than 5,000 Americans, those who said they were ... likely to report higher levels of satisfaction with their care, ...
... have discovered the brain patterns associated with amusia or tone ... associated with other learning disorders like dyslexia. // ... are tone deaf -- in scientific terms, suffering from amusia ... note from another. The disorder can be congenital, present from ...
... before. The problem seems to be worse now that scientists ... proves, when it comes to being overweight, past is most ... shows that we can't afford to wait," said Vivien Morris, ... that brought the girls to the health center's pool, a ...
Cached Medicine News:Health News:Critically Ill Patients More At Risk Of Infection If Glucose Is Present In Their Lung Secretions 2Health News:Early Awareness About Weight Management Needed To Tackle Lifelong Obesity 2
the LabOne Healthcare Group markets laboratory testing to physicians, patients, managed care companies, self-insured employers, wellness companies and hospitals....
... ideal hemostatic gauze for a variety of inpatient ... iX is easy to handle and can be ... sites that are often a challenge faced by ... used to control bleeding in outpatient procedures such ...
Sharp tipped straight scissors. For cutting in the iris plane or cutting peripheral membranes. May also be useful in ROP cases....
Microscissors : Horizontal Scissors...
Medicine Products: